Andrew L Coveler

18PUBLICATIONS
118CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Innate immunityMolecular targetsTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|May 04, 2026
Safety and immunogenicity of a tri-antigen vaccine targeting IGFBP-2, HER2, and IGF-IR in participants with non-metastatic breast cancer.

|Mar 14, 2026
Correction: Chang et al. Exercise Guidelines in Pancreatic Cancer Based on the Dietz Model. Cancers 2025, 17, 630.

Philip J Chang, Andrew E Hendifar, Gillian Gresham

|Feb 13, 2026
Phase II Study of Pegvorhyaluronidase Alfa (PEGPH20) and Pembrolizumab for Patients with Hyaluronan-High, Pretreated Metastatic Pancreatic Ductal Adenocarcinoma: PCRT16-001.

Elena Gabriela Chiorean, Sheela R Damle, David B Zhen

|Dec 15, 2025
Rechallenge With an Epidermal Growth Factor Receptor Inhibitor in Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis.

Amy H Huang, Gin Yi Lee, Chuan Angel Lu

|Jul 17, 2025
Targeting metabolism in pancreatic ductal adenocarcinoma: challenges and insights from the AVENGER 500 trial.

Elizabeth S Nakasone, Andrew L Coveler

|Jun 13, 2025
Phase Ia/Ib Study of Afatinib with Capecitabine in Patients with Refractory Solid Tumors and Pancreaticobiliary Cancers.

Gentry G King, Kelsey K Baker, Andrew L Coveler

Pageof 3

Frequent Collaborators

3 joint publications

David B Zhen

3 joint publications

Rachael A Safyan

3 joint publications

Elena Gabriela Chiorean

2 joint publications

Madhulika G Varma